The Burnt Toast Podcast [PREVIEW] The State of GLP-1 Discourse
Feb 12, 2026
Two women dig into how media frames GLP-1 drugs and whether the backlash has begun. They unpack ableism around lifelong medications and who gets written out of the conversation. They critique a major news headline and point out missing context about side effects, cost, and why people stop these treatments.
AI Snips
Chapters
Transcript
Episode notes
Regain After Stopping Was Predictable
- Media frames GLP-1 weight regain as a shocking surprise despite obvious drug biology.
- Virginia Sole-Smith argues expecting permanent weight loss after stopping a drug was naive.
Oprah's Public GLP-1 Experience
- Virginia recounts Oprah stopping a weight-loss drug and regaining weight, then calling it a 'lifetime thing.'
- She notes Oprah's endorsement aligns with Weight Watchers marketing incentives.
Aversion To Lifelong Meds Is Ableist
- Resistance to lifelong medication often rests on ableist ideas about strength and autonomy.
- Corinne Fay and Virginia note many chronic conditions require ongoing meds without stigma.